Federation des caisses Desjardins du Quebec’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $44.6K | Buy |
4,751
+1,320
| +38% | +$12.4K | ﹤0.01% | 1582 |
|
2025
Q1 | $24.4K | Buy |
3,431
+1,500
| +78% | +$10.7K | ﹤0.01% | 1665 |
|
2024
Q4 | $22.5K | Buy |
1,931
+1,750
| +967% | +$20.4K | ﹤0.01% | 1643 |
|
2024
Q3 | $3.72K | Hold |
181
| – | – | ﹤0.01% | 2143 |
|
2024
Q2 | $4.05K | Hold |
181
| – | – | ﹤0.01% | 2003 |
|
2024
Q1 | $4.98K | Hold |
181
| – | – | ﹤0.01% | 1959 |
|
2023
Q4 | $5.52K | Sell |
181
-1,845
| -91% | -$56.3K | ﹤0.01% | 1888 |
|
2023
Q3 | $64.1K | Hold |
2,026
| – | – | ﹤0.01% | 1252 |
|
2023
Q2 | $82.6K | Hold |
2,026
| – | – | ﹤0.01% | 1207 |
|
2023
Q1 | $75.5K | Buy |
2,026
+6
| +0.3% | +$224 | ﹤0.01% | 1211 |
|
2022
Q4 | $70.5K | Buy |
2,020
+1,230
| +156% | +$42.9K | ﹤0.01% | 1361 |
|
2022
Q3 | $44.2K | Buy |
+790
| New | +$44.2K | ﹤0.01% | 1535 |
|
2018
Q3 | – | Sell |
-600
| Closed | -$16.4K | – | 2173 |
|
2018
Q2 | $16.4K | Hold |
600
| – | – | ﹤0.01% | 1617 |
|
2018
Q1 | $12.7K | Sell |
600
-50
| -8% | -$1.06K | ﹤0.01% | 1649 |
|
2017
Q4 | $12.5K | Buy |
+650
| New | +$12.5K | ﹤0.01% | 1666 |
|